Quince Therapeutics's total assets for Q2 2025 were $117.21M, an increase of 9.45% from the previous quarter. QNCX total liabilities were $105.47M for the fiscal quarter, a 19.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.